PSMA-Targeted 18F-DCFPyL PET/CT Imaging of Clear Cell Renal Cell Carcinoma: Results from a Rapid Autopsy

European Urology - Tập 71 Số 1 - Trang 145-146 - 2017
Michael A. Gorin1, Steven P. Rowe2, Jody E. Hooper3, Max Kates1, Hans-Joerg Hammers4, Zsolt Szabó2, Martin G. Pomper2, Mohamad E. Allaf1
1The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
2The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA
3Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD USA.
4Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ristau, 2014, The prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research, Urol Oncol, 32, 272, 10.1016/j.urolonc.2013.09.003

Rowe SP, Gorin MA, Allaf ME, et al. PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges. Prostate Cancer Prostatic Dis. In press. http://dx.doi.org/10.1038/pcan.2016.13.

Chang, 1999, Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature, Cancer Res, 59, 3192

Chang, 2001, Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen, Urology, 57, 801, 10.1016/S0090-4295(00)01094-3

Baccala, 2007, Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms, Urology, 70, 385, 10.1016/j.urology.2007.03.025

Rowe, 2015, Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT, Ann Nucl Med, 29, 877, 10.1007/s12149-015-1017-z

Sawicki LM, Buchbender C, Boos J, et al. Diagnostic potential of PET/CT using a 68Ga-labelled prostate-specific membrane antigen ligand in whole-body staging of renal cell carcinoma: initial experience. Eur J Nucl Med Mol Imaging. In press. http://dx.doi.org/10.1007/s00259-016-3360-2.

Rhee, 2016, MP03-12 Staging advanced and metastatic clear cell renal cell carcinoma with 68-gallium PSMA PET for treatment planning [abstract], J Urol, 195, e23, 10.1016/j.juro.2016.02.1905

Thông tin
Thông tin xuất bản

European Urology

Tập 71 Số 1

145-146

Thông tin tác giả